Fosrenol lanthanum carbonate: Phase III extension data; approvable letter in U.S.; under EU review

In an open-label extension of a 6-month European Phase III study, serum phosphorus was maintained throughout the study in

Read the full 195 word article

How to gain access

Continue reading with a
two-week free trial.